06.02.2013 Views

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

Monograph on the Potential Human Reproductive and ... - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BISPHENOL A<br />

Table 82<br />

Summary of High Utility Developmental Toxicity Studies (Multiple Dose Levels)<br />

Bisphenol A dose level (mg/kg bw/day) Reference<br />

Model (treatment) Endpoint NOAEL LOAEL BMD 10 BMDL 10 BMD 1SD BMDL 1SD<br />

Rat<br />

Han–Wistar (drinking Male reproductive organ Z0.775–4.022 Cagen et al.<br />

water from before weights, sperm producti<strong>on</strong>, (high dose) (1999b)<br />

mating through testicular histopathology<br />

gestati<strong>on</strong> <strong>and</strong> lactati<strong>on</strong>)<br />

CD (gavage, 2-generati<strong>on</strong>s Prenatal or postnatal growth Z0.2 Ema et al.<br />

exposure including or survival, developmental (high dose) (2001)<br />

pre-<strong>and</strong> postnatal l<strong>and</strong>marks, anogenital distance,<br />

development periods) age of puberty, fertility,<br />

estrous cyclicity, or<br />

sperm counts<br />

Sprague–Dawley dam k Live fetuses/litter 300 1000 929 348 982 713 Kim et al.<br />

(gavage GD 1–20) (2001b)<br />

k Male body weight 100 300 456 339 694 497<br />

k Female body weight 300 1000 439 328 682 490<br />

k Ossificati<strong>on</strong> 300 1000<br />

Sprague–Dawley dam Volume of SDN-POA, age or Z320 Kw<strong>on</strong> et al.<br />

(gavage GD 11–PND 20) weight at vaginal opening (high dose) (2000)<br />

or first estrous, estrous cyclicity,<br />

mean lordosis intensity, prostate<br />

weight, or histopathology in<br />

ventral prostate, ovary, or uterus<br />

CD dams (gavage Implantati<strong>on</strong> sites, resorpti<strong>on</strong>s, Z640 Morrissey et al.<br />

GD 6–15) body weight, viability, sex ratio, (high dose) (1987)<br />

<strong>and</strong> malformati<strong>on</strong>s<br />

Sprague–Dawley m Uterine epi<strong>the</strong>lial cell nuclei 0.1 Schönfelder<br />

dam (gavage (low dose) et al. (2004)<br />

GD6–PND 21)<br />

m Uterine epi<strong>the</strong>lial nuclei with 0.1<br />

c<strong>on</strong>densed chromatin (low dose)<br />

m Uterine epi<strong>the</strong>lial cells 0.1<br />

with cavities (low dose)<br />

k ERb-positive cells in 0.1<br />

uterine tissue (low dose)<br />

kThickness of uterine 0.1 50<br />

luminal epi<strong>the</strong>lium<br />

m ERa-positive cells in 0.1 50<br />

uterine epi<strong>the</strong>lium<br />

Wistar-derived Delayed vaginal opening 0.1 50 68 51 35 16 Tinwell et al.<br />

Alderley–Park (2002)<br />

dams (gavage GD 6–21)<br />

k Sperm count/testis 0.1 50 55 30 57 31<br />

k Sperm count/g testis 0.1 50 81 41 68 34<br />

k Daily sperm count/testis 0.1 50 56 31 59 31<br />

k Daily sperm count/g testis 0.1 50 83 42 70 34<br />

Sprague–Dawley (dietary, Live F1 pups/litter 47.5 475 268 192 559 394 Tyl et al.<br />

multiple generati<strong>on</strong>s (2000b, 2002b)<br />

with exposure during<br />

pre-<strong>and</strong> post natal<br />

development)<br />

Live F2 pups/litter 47.5 475 422 152 459 294<br />

Live F3 pups/litter 47.5 475 236 174 376 286<br />

F1 body weight, PND 4 47.5 475 406 283 561 400<br />

F1, F2, or F2 body weight, PND 7 47.5 475 217–328 183–257 265–410 218–313<br />

F1, F2, or F2 body weight, PND 14 47.5 475 183–243 163–209 177–227 153–191<br />

F1, F2, or F2 body weight, PND 21 47.5 475 208–252 166–226 223–267 175–220<br />

m Age at F1 vaginal opening 47.5 475 394 343 206 176<br />

m Age at F2 vaginal opening 47.5 475 404 336 277 228<br />

m Age at F3 vaginal opening 47.5 475 471 401 396 203<br />

m Age at F1 preputial separati<strong>on</strong> 4.75 47.5 466 411 188 163<br />

m Age at F2 preputial separati<strong>on</strong> 47.5 475 300 255 241 203<br />

m Age at F3 preputial separati<strong>on</strong> 47.5 475 547 473 222 189<br />

Mating, fertility, pregnancy, or Z475<br />

gestati<strong>on</strong>al indices; (high dose)<br />

precoital interval,<br />

postimplantati<strong>on</strong> loss,<br />

estrous cyclicity,<br />

<strong>and</strong> reproductive<br />

organ histopathology;<br />

sperm count, morphology<br />

or motility;<br />

Birth Defects Research (Part B) 83:157–395, 2008<br />

321

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!